Cargando…

Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23

PURPOSE: Tumor-induced osteomalacia (TIO) is characterized by hypophosphatemia caused by a phosphaturic mesenchymal tumor. While surgical resection of the tumor leads to a cure, identification of the responsible tumor is challenging. Recently, several studies showed that systemic sampling of fibrobl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji-Yeon, Park, Hye-Sun, Han, Seunghee, Lim, Jiyu Kelly, Hong, Namki, Park, Sung Il, Rhee, Yumie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552653/ https://www.ncbi.nlm.nih.gov/pubmed/28792142 http://dx.doi.org/10.3349/ymj.2017.58.5.981

Ejemplares similares

Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
por: Westerberg, Per-Anton, et al.
Publicado: (2012)

Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia
por: Then, Cornelia, et al.
Publicado: (2020)

C-Arm Computed Tomography-Assisted Adrenal Venous Sampling Improved Right Adrenal Vein Cannulation and Sampling Quality in Primary Aldosteronism
por: Park, Chung Hyun, et al.
Publicado: (2018)

Oncogenic Osteomalacia with Elevated Fibroblast Growth Factor 23: A Rare Case of Paranasal Sinus Tumor Onset
por: Rigante, Mario, et al.
Publicado: (2019)

Sinonasal Glomangiopericytoma Causing Oncogenic Osteomalacia
por: Lee, Gang Gyu, et al.
Publicado: (2014)

Nasal Hemangiopericytoma Causing Oncogenic Osteomalacia
por: Cho, Sung Il, et al.
Publicado: (2012)

Update on Preoperative Parathyroid Localization in Primary Hyperparathyroidism
por: Park, Hye-Sun, et al.
Publicado: (2022)

Selective blood sampling for FGF-23 in tumor-induced osteomalacia
por: Schober, Hans-Christof, et al.
Publicado: (2017)

A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling
por: Horinouchi, Yasuo, et al.
Publicado: (2023)

Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022)

Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing
por: Park, Hye-Sun, et al.
Publicado: (2022)

Oncogenic osteomalacia secondary to glomus tumor
por: Raj, Rishi, et al.
Publicado: (2021)

Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level
por: Amblee, Ambika, et al.
Publicado: (2014)

Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions.
por: Park, Y. K., et al.
Publicado: (1994)

Machine Learning Applications in Endocrinology and Metabolism Research: An Overview
por: Hong, Namki, et al.
Publicado: (2020)

Oncogenic Osteomalacia as a Harbinger of Recurrent Osteosarcoma
por: Lamont, Elizabeth B., et al.
Publicado: (1999)

Oncogenic osteomalacia diagnosed by blood pool scintigraphy
por: Palaniswamy, Shanmuga Sundaram, et al.
Publicado: (2011)

Favorable Effects of Burosumab on Fibroblast Growth Factor 23-Related Osteomalacia: A Case Report
por: Oe, Yuki, et al.
Publicado: (2021)

Oncogenic osteomalacia: A reversible metabolic bone disorder
por: Dhanwal, Dinesh Kumar
Publicado: (2010)

Oncogenic osteomalacia: Problems in diagnosis and long-term management
por: Dhammi, Ish K, et al.
Publicado: (2010)

A case of oncogenic osteomalacia owing to inguinal tumor
por: Tonello, Luiza, et al.
Publicado: (2017)

Abstract 159: Glomus tumour presenting with oncogenic osteomalacia
por: Mathew, Anu
Publicado: (2022)

Ethmoid glomangioma and oncogenic osteomalacia: a case report
por: Muniz, Camila R., et al.
Publicado: (2021)

Effective localization in tumor-induced osteomalacia using (68)Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI
por: Kawai, Shintaro, et al.
Publicado: (2017)

Circulating MicroRNA-23a-5p Is a Potential Biomarker for Recovery of Bone Mass After Parathyroidectomy in Primary Hyperparathyroidism
por: Lee, Seunghyun, et al.
Publicado: (2021)

Qualitative focus group interview study of communication between patients, dentists and physicians for efficient osteonecrosis of the jaw practices
por: Choi, Yiseul, et al.
Publicado: (2022)

ODP077 Adipopenia is associated with low bone mass in community-dwelling non-underweight adults, independent of sarcopenia
por: Lee, Seunghyun, et al.
Publicado: (2022)

Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia
por: Amaratunga, Eluwana A, et al.
Publicado: (2021)

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
por: Kinoshita, Yuka, et al.
Publicado: (2018)

Scintigraphic Findings in FGF23-related Hypophosphatemic Osteomalacia
por: Fujita, Naoya, et al.
Publicado: (2023)

Association of Shift Work with Normal-Weight Obesity in Community-Dwelling Adults
por: Ahn, Chul Woo, et al.
Publicado: (2022)

ODP274 Shift work is associated with normal weight obesity in community-dwelling adults
por: Ahn, Chul Woo, et al.
Publicado: (2022)

Effects of Altered Calcium Metabolism on Cardiac Parameters in Primary Aldosteronism
por: Lim, Jung Soo, et al.
Publicado: (2018)

Parathyroid venous sampling for the preoperative localisation of parathyroid adenoma in patients with primary hyperparathyroidism
por: Ho, Joon, et al.
Publicado: (2022)

Two Cases of Frontal Variation of Idiopathic Calvarial Thinning—Therapeutic Effect of Denosumab and Romosozumab
por: Baek, Seungjin, et al.
Publicado: (2023)

Osteomalacia and myelofibrosis as a manifestation of vitamin D deficiency
por: Song, Il-Geun, et al.
Publicado: (2014)

Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease
por: Hu, Fangke, et al.
Publicado: (2016)

The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia
por: Zhang, Qian, et al.
Publicado: (2016)

Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report
por: Obo, Takahiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vpj0s8i4m1lrb3b3c31c2rqi2f